Prevalence of Mycobacterium tuberculosis infection among injection drug users in Toronto

CMAJ. Canadian Medical Association Journal

Volumn 160, Issue 6, 1999, Pages 799-802

  Rusen, I D ^a   Yuan, Lilian ^a   Millson, Margaret E ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANADA; DRUG ABUSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; SCREENING; STATISTICS; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0033596970     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. 1. Brancker A, Enarson DA, Grzybowski S, Hershfield ES, Jeanes CWL. A statistical chronicle of tuberculosis in Canada. Part II: Risk today and control. Health Rep 1992;4:277-91.
2. 2. Kerbel D. Epidemiology of tuberculosis in Ontario 1905. Public Health Epidemiol Rep Ont 1997;8:81 -93.
3. 3. Lichtenstein PM. Narcotic addiction. In: O'Donnell JA, Ball JC, editors. Narcotic addiction. New York: Harper & Row; 1966. p. 23-34.
4. 4. Perlman DC, Salomon N, Perkins MP, Yancovitz S, Paone D, Des Jarlais DC. Tuberculosis in drug users. Clin Infect Dis 1995;21:1253-64.
5. 5. Reyes JC, Robles RR, Colón HM, Marrero CA, Castillo X, Meléndez M. M. tuberculosis and HIV infection among crack and injection drug users in San Juan, Puerto Rico [abstract]. In: Abstracts: American Public Health Association 123rd annual meeting & exhibition; San Diego; 1995 Oct 29-Nov 2. Washington: The Association; 1995.
6. 6. MacGregor RR, Dunbar D, Graziani AL. Tuberculin reactions among attendees at a methadone clinic: relation to infection with human immunodeficiency virus. Clin Infect Dis 1994;19:1100-4.
7. 7. Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, et al. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997;11:F59-65.
8. 8. Des Jarlais DC, Hagan H, Friedman SR, Friedman P, Goldberg D, Frischer M, et al. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA 1995;274:1226-31.
9. 9. Al-Jahdali H, Menzies R. Tuberculosis: old disease, new diagnostic tests. Can J Diagnosis 1995;12(2):73-83.
10. 10. Menzies D, Chan CH, Vissandjee B. Impact of immigration on tuberculosis infection among Canadian-born school children and young adults in Montreal. Am J Respir Crit Care Med 1997;156:1915-21.
11. 11. Stein SC. Tuberculosis infection in a metropolitan city: an epidemiological review. Am Rev Respir Dis 1968;99:298.
12. 12. Bilgi C. Tuberculous infection in an urban population: analysis of 1000 routine Mantoux tests. Can J Public Health 1980;71:337-9.
13. 13. Perlman DC, Perkins MP, Salomon N, et al. Tuberculosis screening at a syringe exchange program: factors associated with returning for skin test interpretation [abstract]. In: Abstracts of the 124th American Public Health Association annual meeting & exhibition; New York; 1996. Washington: The Association; 1996. p. 77.
14. 14. Markowitz N, Hansen NI, Wilcosky TC, et al. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann Intern Med 1993; 119:185-93.
15. 15. Pesanti E. The negative tuberculin test: tuberculin, HIV and anergy panels. Am J Respir Crit Care Med 1994;149:1699-709.
16. 16. Howard TP, Solomon DA. Reading the tuberculin skin test. Arch Intern Med 1988;148:2457-9.